Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine

Author： Fox Anthony W  

Publisher： Informa Healthcare

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.5, 2012-09, pp. : 513-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Butalbital/paracetamol/caffeine withdrawal: Delirium (first report with paracetamol): case report

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Naproxen/sumatriptan tops either drug alone for migraine

By  

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Naproxen/sumatriptan a single-tablet attack on migraine

By  

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

By Tfelt-Hansen Peer   Hougaard Anders  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 91-103

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Rizatriptan and Sumatriptan versus Cafergot ® in the Acute Treatment of Migraine

By Zhang Lihua   Hay Joel W.  

CNS Drugs, Vol. 19, Iss. 7, 2005-01 ,pp. : 635-642

Adis International

Access to resources Recommend Favorite